Point72 Hong Kong’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-19,217
Closed -$2.49M 521
2023
Q4
$2.49M Buy
+19,217
New +$2.65M 0.15% 177
2021
Q3
Sell
-1,409
Closed -$57K 1918
2021
Q2
$57K Buy
+1,409
New +$58.4K ﹤0.01% 1442
2020
Q4
Sell
-759
Closed -$17K 1677
2020
Q3
$17K Buy
+759
New +$19.4K ﹤0.01% 899
2019
Q3
Sell
-150
Closed -$2K 957
2019
Q2
$2K Buy
+150
New +$2.68K ﹤0.01% 981
2019
Q1
Sell
-20
Closed 991
2018
Q4
$0 Buy
+20
New +$355 ﹤0.01% 859
2017
Q3
Sell
-42
Closed -$1K 769
2017
Q2
$1K Buy
42
+25
+147% +$528 ﹤0.01% 698
2017
Q1
$0 Buy
+17
New +$268 ﹤0.01% 714

Other funds holding ACLS

Point72 Hong Kong's ACLS Position: Q1 2024 in Review

Point72 Hong Kong sold out of Axcelis (ACLS) in Q1 2024, closing a stake of 19,217 shares — an estimated $2.49M sold.

Point72 Hong Kong first reported a position in ACLS in Q1 2017 and held it in 7 quarters. The position peaked at $2.49M in Q4 2023. 385 funds tracked by Wall St. Rank hold ACLS as of Q1 2024.

  • Point72 Hong Kong reported no remaining Axcelis position as of Q1 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 19,217 Axcelis shares in Q1 2024, an estimated $2.49M.
  • Point72 Hong Kong first reported a position in Axcelis in Q1 2017 and held it in 7 quarters.
  • Point72 Hong Kong's Axcelis position peaked at $2.49M in Q4 2023.
  • 385 funds tracked by Wall St. Rank held Axcelis as of Q1 2024.

Based on Point72 Hong Kong's 13F filing for Q1 2024, filed 15 May 2024.